0 Comments
0 Shares
100 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
CD Antigen Targeted Oncology Therapy Market Analysis"Cluster of Differentiation (CD) Antigen Cancer Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the Cluster of Differentiation (CD) Antigen Cancer Therapy Market The global Cluster Of Differentiation (CD) antigen cancer therapy market size was valued at USD 11.86 billion in 2025 and is expected to reach USD 22.61 billion...0 Comments 0 Shares 375 Views 0 Reviews
-
Cyclin Dependent Kinase Inhibitor Market – Precision Oncology Advancing Through Targeted Cell Cycle TherapyMarket Overview The cyclin dependent kinase inhibitor market is expanding rapidly as oncology shifts toward precision therapies that halt uncontrolled cell division at its source. These inhibitors block specific enzymes responsible for driving the cell cycle in cancer cells, particularly in breast cancer and other hormone-receptor-positive malignancies. Growth is fueled by rising cancer...0 Comments 0 Shares 99 Views 0 Reviews
-
Generic Oncology Drug Market – Complex Generics and Targeted Therapy AccessMarket Overview The generic oncology drug market is advancing into complex generics for targeted therapies including kinase inhibitors, immunomodulatory drugs, and nanomedicine formulations that present formulation and bioequivalence challenges beyond traditional small molecules. As patents expire on oral targeted agents that have transformed cancer outcomes, complex generic development is...0 Comments 0 Shares 95 Views 0 Reviews
-
How Rising Oncology Research and Targeted Cancer Therapy Development Are Driving the Global Kinesin Like Protein Kif11 MarketThe global Kinesin Like Protein Kif11 market is expanding as pharmaceutical companies, research institutions, and hospitals invest in advanced molecular targets to support cancer research, drug discovery, and targeted therapy development. The market was valued at USD 450 million in 2023 and is projected to reach USD 980 million by 2032, growing at a CAGR of 9.1%. The Kinesin Like Protein Kif11...0 Comments 0 Shares 56 Views 0 Reviews
-
Kirsten Rat Sarcoma (KRAS) Market – Oncology Breakthroughs & Targeted Therapy Outlook"Future of Executive Summary Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market research report is a sure solution to get market insights with which...0 Comments 0 Shares 956 Views 0 Reviews
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 Comments 0 Shares 1K Views 0 Reviews
-
Radiotheranostics Market: Emerging Applications in Oncology and Targeted Radionuclide TherapyMarket Overview Polaris Market Research’s latest research report, titled Radiotheranostics Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a market...0 Comments 0 Shares 465 Views 0 Reviews
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has incorporated...0 Comments 0 Shares 1K Views 0 Reviews
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Comments 0 Shares 5K Views 0 Reviews
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comments 0 Shares 5K Views 0 Reviews
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Comments 0 Shares 12K Views 0 Reviews
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comments 0 Shares 1K Views 0 Reviews
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 2K Views 0 Reviews
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 9K Views 0 Reviews
-
Global Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 1K Views 0 Reviews
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an overview...0 Comments 0 Shares 8K Views 0 Reviews
-
Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Market The global Poly (ADP-Ribose) Polymerase (PARP) inhibitors market size was valued at USD 10.00 billion in 2024 and is expected to reach USD 23.89 billion by 2032, at a CAGR of 11.50% during the forecast period This...0 Comments 0 Shares 2K Views 0 Reviews
-
Radiation-Induced Dermatitis Drug Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Radiation-Induced Dermatitis Drug Marke The global radiation-induced dermatitis drug market size was valued at USD 489.95 million in 2024 and is expected to reach USD 650.17 million by 2032, at a CAGR of 3.60% during the forecast period The market research studies of...0 Comments 0 Shares 3K Views 0 Reviews
-
Uterine Carcinosarcoma Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market The Uterine Carcinosarcoma Market was valued at USD 25.72 billion in 2025 and is projected to reach USD 42.56 billion by 2033, growing at a CAGR of 6.50% from 2026 to 2033. The market is witnessing steady growth driven by increasing incidence of rare and...0 Comments 0 Shares 2K Views 0 Reviews
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Comments 0 Shares 3K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali